期刊文献+

多囊卵巢综合征代谢组学研究进展 被引量:10

Research progress of polycystic ovary syndrome based on metabolomics
原文传递
导出
摘要 收集最近发表的应用代谢组学技术研究多囊卵巢综合征的国内外文献,总结与多囊卵巢综合征(PCOS)发生相关的代谢物及代谢通路。从代谢组学角度探讨PCOS的发病机制及诊断、治疗进展,为PCOS的诊断和治疗提供代谢组学的依据。与PCOS发生相关的代谢物涉及碳水化合物、脂肪、蛋白质和激素;胰岛素抵抗、肥胖等与PCOS的代谢异常密切相关;药物可通过改善代谢紊乱治疗PCOS。代谢组学技术的应用有助于进一步明确PCOS的代谢紊乱,筛选的病变标志物有助于疾病的预测诊断和远期并发症的预防。 Gather the pathogenesis, diagnosis and therapy progress for polycystic ovary syndrome based on metabonom- ics, and summarize the metabolites and metabolic pathways associated with PCOS according to recent metabolomic stud- ies. PCOS associated metabolites were involved in carbohydrate, fat, protein and hormone metabolism. Insulin resistance and obesity are closely related to the PCOS. Treatment of PCOS seems to modify the metabolism disorder. Application of metabonomics technology is helpful to further clarify the metabolic disorder of PCOS. Metabolic markers provide the ba- sis for clinical diagnosis, treatment and prevention of long-term complications of the disease.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2016年第5期489-494,共6页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 多囊卵巢综合征 代谢组学 代谢物 polycystic ovary syndrome metabolomics metabolite
作者简介 通讯作者:侯丽辉,电子信箱:houlihui2007@sina.com
  • 相关文献

参考文献50

  • 1Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J]. Fertil Steril, 2009, 91 (2) : 456- 488.
  • 2崔玉倩,陈子江.多囊卵巢综合征基因学研究进展[J].中国实用妇科与产科杂志,2013,29(11):902-906. 被引量:6
  • 3Diamanti-Kandarakis E, Kandarakis H, Legro RS. The role of genes and environment in the etiology of PCOS[J]. Endocr, 2006, 30( 1 ) : 19-26.
  • 4乔杰,尹太郎.多囊卵巢综合征认知与对策[J].中国实用妇科与产科杂志,2013,29(11):841-844. 被引量:78
  • 5Kelly CCJ, Lyall H, Petrie JR, et al. Low grade chronic inflamma- tion in women with polycystic ovarian syndrome[J]. J Clin Endo- crinol Metab, 2001,86 (6) : 2453-2455.
  • 6Karadeniz M, Erdogan M, Tamsel S, et al. Oxidative stress mark- ers in young patients with polyeystie ovary syndrome: the rela- tionship between insulin resistances[J]. Exp Clin Endocrin Diab, 2008,116 (4) :231-235.
  • 7Eseobar-Morreale HF. Polycystic ovary syndrome: treatment strategies and management[J]. Expert Opin Pharmacoth, 2008,9 (17) :2995-3008.
  • 8The Rotterdam ESHRE/ASRM Sponsored PCOS Consensus- Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J]. Hum Repot, 2004,19 ( 1 ) : 41-47.
  • 9Gonzalez F. Inflammation in polycystic ovary syndrome : under- pinning of insulin resistance and ovarian dysfunction[J]. Ste-roids,2012,77(4):300-305.
  • 10Atiomo W, Daykin CA. Metabolomic biomarkers in women with polycystic ovary syndrome : a pilot study[J]. Mol Hum Re- prod, 2012,18( 11 ) : 546-553.

二级参考文献94

共引文献121

同被引文献116

引证文献10

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部